Chemotherapy response is an important predictor of local recurrence in ewing sarcoma
Authors:
- Patrick P. LinPLPatrick P. Lin
- Jeana S. KellyJKJeana S. Kelly
- Alan W. YaskoAYAlan W. Yasko
Open Access
Abstract
BACKGROUND.: Local recurrence in Ewing sarcoma is associated with a poor prognosis. The purpose of the study was to determine the factors that predict local recurrence after surgical treatment of the primary tumor.METHODS.: Between 1990 and 2001, 64 patients underwent surgical resection of Ewing sarcoma. Surgical margins were assessed histologically and radiologically. Response to preoperative chemotherapy was determined by detailed specimen mapping. Local recurrence‐free survival (LRFS) was calculated by Kaplan–Meier analysis. Multivariate analysis was performed with the Cox proportional hazards model.RESULTS.: A number of factors were found to be associated with local recurrence on univariate analysis. Patients with a good response to chemotherapy (≥90% tumor necrosis), had superior LRFS at 5 years (86% vs 51%, P = .015). Central site of disease was associated with an increased rate of recurrence. The LRFS at 5 years was 50% for the chest wall, 74% for pelvic/scapular, and 86% for extremity tumors (P = .083). Positive surgical margin was not a strong predictor of recurrence (P = .72). A critical analysis of minimal surgical margin based on preoperative magnetic resonance imaging (MRI) and computed tomography (CT) scans also failed to reveal an association between margin and local recurrence. In multivariate analysis, the 2 independent predictors of local recurrence were histological response to chemotherapy and central site of disease.CONCLUSION.: Local recurrence after surgical resection is a complex phenomenon. An important predictive factor is the response to chemotherapy. In the current study, this seems to have the largest impact. Central site of disease may be a second independent predictive factor. Cancer 2007;109:603–611. © 2006 American Cancer Society.Keywords
This publication has 27 references indexed in Scilit:
- Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of BoneNew England Journal of Medicine, 2003
- Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomographyCancer, 2002
- Non-metastatic Ewing's sarcoma of the ribsEuropean Journal of Cancer, 2002
- Survival after recurrence of Ewing TumorsCancer, 2002
- Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resectionThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Pediatric chest wall Ewing's sarcomaJournal of Pediatric Surgery, 2000
- Ewing's Sarcoma of the PelvisClinical Orthopaedics and Related Research, 2000
- Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcomaEuropean Journal of Cancer, 1999
- A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Phase I Trial of ImmTher, a New Liposome-Incorporated Lipophilic Disaccharide TripeptideJournal of Immunotherapy, 1991